XORTX Therapeutics Inc.
Tuesday, June 04, 2024
Other
Company Presentation Theater 1
XORTX Therapeutics, a late-stage clinical pharmaceutical company dedicated to developing innovative therapies to improve the quality of life of patients with progressive kidney disease. Our programs are designed to manage aberrant purine metabolism and reduce high uric acid and slow progression of kidney disease.
Company Website:
http://XORTX.com
Lead Product in Development:
XRx-008 program for ADPKD
Number Of Unlicensed Products (For Which You Are Seeking Partners):
XRx-008 program for ADPKD
Exchange
Nasdaq
Toronto Venture Exchange
Ticker
XRTX - Nasdaq
XRTX - TSXV
Company HQ City
Calgary
Company HQ State
Alberta
Company HQ Country
Canada
CEO/Top Company Official
Allen Davidoff
Development Phase of Primary Product
Phase III
Primary Speaker
)
)
)
)
)
)
){kind=logo}
){kind=logo}
.png/fit-in/500x500/filters:no_upscale())